Back to List View Graph View

Ferroptosis

Ferroptosis is a form of regulated cell death, distinct from apoptosis and necroptosis, defined by the iron-dependent accumulation of lipid peroxides in cellular membranes to lethal levels.

Where the papers sit

47 papers from the last 6 months study ferroptosis directly · updated from PubMed 16 Nov 2026

  • Ferroptosis in Cancer Therapy

    Cancer treatment is moving toward deliberately inducing ferroptosis by combining iron supply, lipid peroxidation and GPX4 disruption. Nanoparticles, RNA interference, sonodynamic therapy and repurposed drugs such as irinotecan, nitazoxanide and sorafenib recur as delivery or sensitization strategies. Tumor-specific mechanisms include HSPA5, OTUD6B, ACO1-TPI1, mitochondrial homeostasis and macrophage signaling. Immune remodeling and checkpoint blockade are emerging alongside direct tumor killing.

    19 papers · 40.4%

  • Oxidative Ferroptosis Mechanisms

    Oxidative stress, glutathione depletion and GPX4 loss remain the central route to ferroptosis across cancer, neurological disease, infection and tissue injury. Cancer studies favor inducing this pathway with curcumin, arsenic trioxide, atranorin and synthetic compounds, while organ-protection studies aim to suppress it with exosomes or antioxidant nanoparticles. Nrf2, FTH1 and GPX4 repeatedly shape drug resistance and treatment response. The main unresolved issue is how to separate tumor killing from ferroptotic damage in normal tissues.

    14 papers · 29.8%

  • Cell Death and Immunotherapy

    Multi-omics and single-cell profiling are linking regulated cell death to immune evasion, therapeutic resistance and patient stratification in cancer. Ferroptosis suppression, CD8+ T-cell exhaustion and S100A10-driven immune escape recur as mechanisms limiting immunotherapy. Other studies broaden the scope to copper-dependent death, cardiotoxicity and toxicant-induced epithelial stress, identifying candidate regulators rather than established treatments. The field is moving toward integrated biomarkers that connect cell-death programs with checkpoint response.

    8 papers · 17%

  • NRF2 Control of Ferroptosis

    NRF2 and its KEAP1 regulatory axis are being targeted to control redox defenses and ferroptosis in brain, vascular, wound and retinal disease. Most studies activate NRF2 or its downstream HO-1 and GPX4 defenses to reduce oxidative injury, neuronal death and macrophage ferroptosis. This protective direction contrasts with work using Nrf2/SLC7A11/GPX4 disruption to promote ferroptosis in hepatocellular carcinoma. Whether pathway modulation can achieve tissue selectivity remains open.

    6 papers · 12.8%

PARADIGM SHIFT

Ferroptosis is regulated by neighboring stromal and immune cells rather than being solely a tumor-cell-autonomous process

Lean-adipocyte oxylipin signaling in breast cancer and ultrasound-targeted microbubble destruction in papillary thyroid carcinoma independently show that surrounding cells determine whether tumor ferroptosis occurs. Adipocyte-derived 9S-HODE induces ferroptosis in breast cancer cells, whereas obesity reduces this signal; separately, UTMD suppresses CSF-1, shifts macrophages away from an M2 state, and removes macrophage-mediated protection against ferroptosis in thyroid carcinoma cells 42721252Sep 42656085Aug. The assumption that ferroptosis can be understood mainly by manipulating intracellular tumor pathways therefore gives way to a microenvironmental account in which adipocytes, macrophages, and their secreted signals are therapeutic control points.

NEW DIRECTION

Ferroptosis modulation is used to control astrocyte-to-neuron conversion after hemorrhagic brain injury

Ferroptosis modulation during chemical astrocyte-to-neuron reprogramming in the hemorrhagic brain assigns ferroptosis a role beyond killing diseased or malignant cells or protecting injured cells. The study monitors ferroptosis during in vivo astrocyte-to-neuron conversion after intracerebral hemorrhage and tests whether inhibiting it changes reprogramming efficiency, making ferroptosis a regulator of cellular identity conversion and neural regeneration rather than simply an endpoint of cell injury or a means of tumor therapy 42527413Jul.

Papers

The 47 papers from the last 6 months that study ferroptosis directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Ferroptosis in Cancer Therapy (19)
  1. Development and validation of a ferroptosis and metabolic reprogramming gene signature for risk stratification in bladder urothelial carcinoma: A retrospective multicohort study. Medicine · 17 Oct 2026 PMID 42888597
  2. Metabolic vulnerabilities in multiple myeloma: targeting iron and amino acid metabolism to induce ferroptosis. Apoptosis : an international journal on programmed cell death · 3 Oct 2026 PMID 42829384
  3. Lean adipocyte oxylipin signaling restrains breast cancer through ferroptosis. Science (New York, N.Y.) · 10 Sept 2026 PMID 42721252
  4. Synergistic epigenetic modulation and ferroptosis induction via codelivery of Decitabine and Sorafenib for potent anti-tumor therapy. Drug delivery · 3 Sept 2026 PMID 42690017
  5. PEBP1 Regulates Ferroptosis in Acute Glaucoma: Targeted Therapy Using Engineered Exosomes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 3 Sept 2026 PMID 42687852
  6. Folic-Acid-Modified Fe-TCPP Metal-Organic Frameworks as Sonosensitive Agents and siATAD3A Carriers for Sonodynamic Co-Gene-Ferroptosis Therapy in Triple-Negative Breast Cancer. ACS biomaterials science & engineering · 1 Sept 2026 PMID 42679356
  7. Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC. Cell reports. Medicine · 31 Aug 2026 PMID 42673947
  8. UTMD Suppresses CSF-1 to Drive Macrophage-Mediated Ferroptosis in Papillary Thyroid Carcinoma. Cancer medicine · 27 Aug 2026 PMID 42656085
  9. HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer. Cellular signalling · 22 Aug 2026 PMID 42632529
  10. Targeting FAR1 to inhibit intestinal macrophage ferroptosis: repurposing irinotecan as a novel sepsis therapy. Apoptosis : an international journal on programmed cell death · 19 Aug 2026 PMID 42616198
  11. Prognostic risk modeling based on integrated multi-omics analysis identifies CRY2 as a key regulator in tumor immunity and patient survival in colorectal cancer. Annals of medicine · 4 Aug 2026 PMID 42550740
  12. Mitochondrial ribosomal protein S30 inhibits ferroptosis and promotes tumor progression in hepatocellular carcinoma via suppressing GPX4 ubiquitination. International journal of biological macromolecules · 1 Aug 2026 PMID 42542152
  13. A Ferrous-Supply-Regenerating Lipid Nanoparticle Integrating RNAi Induces Ferroptosis for Cancer Therapy. Small (Weinheim an der Bergstrasse, Germany) · 30 Jul 2026 PMID 42528415
  14. Ferroptosis modulation enhances astrocyte-to-neuron conversion induced by a novel chemical cocktail in the hemorrhagic brain. Signal transduction and targeted therapy · 29 Jul 2026 PMID 42527413
  15. m6A-methylated circFANCB Promotes Gastric Cancer Progression by Regulating Cellular Ferroptosis Through miR-454-3p/CEACAM5. Journal of biochemical and molecular toxicology · 25 Jul 2026 PMID 42502170
  16. Calycosin triggers ferroptosis through modulation of the OTUD6B/GPX4 axis to suppress triple-negative breast cancer. Biochemical and biophysical research communications · 9 Jul 2026 PMID 42424934
  17. Repurposing nitazoxanide as a novel ferroptosis inducer for triple-negative breast cancer via dual disruption of iron homeostasis and the β-catenin/GPX4 axis. Redox report : communications in free radical research · 29 Jun 2026 PMID 42371677
  18. Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer. Cancer research · 15 Jun 2026 PMID 42290280
  19. 5-O-Methylembelin disrupts the ACO1-TPI1 interaction to promote ferroptosis in clear cell renal cell carcinoma. Phytomedicine : international journal of phytotherapy and phytopharmacology · 21 May 2026 PMID 42166976
Oxidative Ferroptosis Mechanisms (14)
  1. Lithium-Doped Hydroxyapatite Nanowires Rejuvenate Senescent Macrophages Via the Lysosome-Dependent Ferroptosis Axis to Promote Aged Bone Regeneration. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 26 Oct 2026 PMID 42928457
  2. Network pharmacology, molecular docking, and experimental validation of the mechanisms of Withaferin a in treating periodontitis. Clinical oral investigations · 9 Sept 2026 PMID 42714624
  3. Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Alleviate Age-Related Insomnia in Rats by Suppressing Neuronal Ferroptosis in the Hippocampal Dentate Gyrus. Neurochemical research · 28 Aug 2026 PMID 42663757
  4. Ferroptosis suppression by MYC confers oxaliplatin resistance in colorectal cancer via FTH1 and GPX4. Cancer chemotherapy and pharmacology · 6 Aug 2026 PMID 42560559
  5. Ferroptosis induction by curcumin through regulating the expression of glutathione peroxidase 4 in papillary thyroid carcinoma. Journal of molecular histology · 4 Aug 2026 PMID 42550316
  6. Atranorin suppresses the LUCAT1/STAT3 axis to induce ferroptotic cell death in ovarian cancer. Molecular biology reports · 24 Jul 2026 PMID 42496762
  7. Neural network-enhanced investigation of ferroptosis and druggability in early-onset alzheimer's disease. Metabolic brain disease · 20 Jul 2026 PMID 42474555
  8. Multifunctional Polydopamine Nanoparticles to Alleviate Oxidative Stress and Inhibit Ferroptosis for Cisplatin-Induced Acute Kidney Injury Therapy. Molecular pharmaceutics · 11 Jul 2026 PMID 42435348
  9. Dihydropyrano[2,3-b]indoles: Novel dual modulators for lung cancer treatment via autophagy inhibition and ferroptosis induction. Bioorganic chemistry · 7 Jul 2026 PMID 42413401
  10. SMURF1-mediated EFEMP1 ubiquitination reverses the resistance of HCC cells to sorafenib by promoting ferroptosis. Biochemical and biophysical research communications · 6 Jul 2026 PMID 42407434
  11. Arsenic trioxide triggers ferroptosis in neuroblastoma via USF1/GPX4 axis. Bioorganic chemistry · 20 Jun 2026 PMID 42322906
  12. Bifunctional inhibitors of β-lactamases and ferroptosis: Design, synthesis and anti-gram-negative bacterial infection evaluation. European journal of medicinal chemistry · 16 Jun 2026 PMID 42302665
  13. Pyrazolone functionalized heterocycles promote breast carcinoma cells ferroptosis via suppressing the Nrf-2/ HMOX-1/GPX-4 signaling axis: combined In Silico and In Vitro investigations. Bioorganic chemistry · 12 Jun 2026 PMID 42284881
  14. Reactive Oxygen Species-Responsive Targeted Polydopamine-Rosmarinic Acid Nanotherapeutics for Ferroptosis-Driven Parkinson's Disease Modulation in Caenorhabditis elegans. ACS applied bio materials · 20 May 2026 PMID 42159234
Cell Death and Immunotherapy (8)
  1. xNNPCD identifies regulators of programmed cell death by integrating perturbation transcriptomes with cancer dependency profiles. NAR cancer · 27 Oct 2026 PMID 42936269
  2. Multi-omics and spatial transcriptomics reveal that S100A10 drives CD8+ T-cell exhaustion and immune evasion in hepatocellular carcinoma through cPLA2-5-LOX-mediated arachidonic acid metabolism and ferroptosis. International immunopharmacology · 13 Sept 2026 PMID 42732672
  3. Metal-dependent cell death in doxorubicin-induced cardiotoxicity and mitigation by luteolin: Network pharmacology and experimental verification. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 30 Jul 2026 PMID 42531631
  4. Integrative multi-omics identifies CYP1B1 as a candidate molecular link between toxicant exposure and ferroptosis-related epithelial stress in COPD. Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 11 Jul 2026 PMID 42435052
  5. A Domino-Synthesized Dicoordinate Copper(I) Bis-imidazopyridine Complex Triggering Cuproptosis/Ferroptosis for Enhanced Cancer Immunotherapy. Angewandte Chemie (International ed. in English) · 3 Jul 2026 PMID 42397940
  6. Multi-omics profiling unveils biological and clinical insights into pulmonary sarcomatoid carcinoma. Cell reports. Medicine · 26 Jun 2026 PMID 42361801
  7. Integrating Machine Learning and Single-Cell Analysis to Reveal the Diagnostic and Therapeutic Value of Regulated Cell Death Mechanisms in Hepatocellular Carcinoma. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 24 Jun 2026 PMID 42338358
  8. Single-Cell Reveal GALNT7-Dependent Ferroptosis Suppression as a Mechanism of Immunotherapy Resistance in Non-Small Cell Lung Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 19 Jun 2026 PMID 42318657
NRF2 Control of Ferroptosis (6)
  1. Acteoside alleviates high glucose-induced ROS accumulation and ferroptosis in ARPE-19 cells by activating the NRF2 signaling pathway. Molecular biology reports · 9 Sept 2026 PMID 42714715
  2. Sesamin Promotes Diabetic Wound Healing by Inhibiting Ferroptosis via the SIRT1/Keap1/Nrf2 Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 31 Aug 2026 PMID 42671318
  3. Development of potent BChE/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosis. European journal of medicinal chemistry · 2 Jul 2026 PMID 42391929
  4. MCL inhibits macrophage ferroptosis through the NRF2/HO-1/GPX4 axis to attenuate carotid atherosclerotic plaque formation. International immunopharmacology · 22 Jun 2026 PMID 42330582
  5. A Keap1-Nrf2 protein-protein interaction inhibitor 4-95 ameliorates cognitive dysfunction by suppressing neuronal ferroptosis. Bioorganic chemistry · 20 Jun 2026 PMID 42322910
  6. DIA-based proteomic analysis reveals Scutellaria barbata D. Don Exosome-like nanovesicles promote ferroptosis in HCC through Nrf2/SLC7A11/GPX4 pathway. Functional & integrative genomics · 28 May 2026 PMID 42209785

By study type

Observational studies and case reports (1)
  1. Development and validation of a ferroptosis and metabolic reprogramming gene signature for risk stratification in bladder urothelial carcinoma: A retrospective multicohort study. Medicine · 17 Oct 2026 PMID 42888597
Human data, design not indexed (3)
  1. xNNPCD identifies regulators of programmed cell death by integrating perturbation transcriptomes with cancer dependency profiles. NAR cancer · 27 Oct 2026 PMID 42936269
  2. Neural network-enhanced investigation of ferroptosis and druggability in early-onset alzheimer's disease. Metabolic brain disease · 20 Jul 2026 PMID 42474555
  3. Integrating Machine Learning and Single-Cell Analysis to Reveal the Diagnostic and Therapeutic Value of Regulated Cell Death Mechanisms in Hepatocellular Carcinoma. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 24 Jun 2026 PMID 42338358
Preclinical: animal, cell and lab studies (36)
  1. Metabolic vulnerabilities in multiple myeloma: targeting iron and amino acid metabolism to induce ferroptosis. Apoptosis : an international journal on programmed cell death · 3 Oct 2026 PMID 42829384
  2. Lean adipocyte oxylipin signaling restrains breast cancer through ferroptosis. Science (New York, N.Y.) · 10 Sept 2026 PMID 42721252
  3. Acteoside alleviates high glucose-induced ROS accumulation and ferroptosis in ARPE-19 cells by activating the NRF2 signaling pathway. Molecular biology reports · 9 Sept 2026 PMID 42714715
  4. Network pharmacology, molecular docking, and experimental validation of the mechanisms of Withaferin a in treating periodontitis. Clinical oral investigations · 9 Sept 2026 PMID 42714624
  5. Synergistic epigenetic modulation and ferroptosis induction via codelivery of Decitabine and Sorafenib for potent anti-tumor therapy. Drug delivery · 3 Sept 2026 PMID 42690017
  6. PEBP1 Regulates Ferroptosis in Acute Glaucoma: Targeted Therapy Using Engineered Exosomes. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 3 Sept 2026 PMID 42687852
  7. Folic-Acid-Modified Fe-TCPP Metal-Organic Frameworks as Sonosensitive Agents and siATAD3A Carriers for Sonodynamic Co-Gene-Ferroptosis Therapy in Triple-Negative Breast Cancer. ACS biomaterials science & engineering · 1 Sept 2026 PMID 42679356
  8. Lysyl oxidase inhibition disrupts mitochondrial homeostasis to create vulnerability to ferroptosis in TNBC. Cell reports. Medicine · 31 Aug 2026 PMID 42673947
  9. Sesamin Promotes Diabetic Wound Healing by Inhibiting Ferroptosis via the SIRT1/Keap1/Nrf2 Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 31 Aug 2026 PMID 42671318
  10. Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Alleviate Age-Related Insomnia in Rats by Suppressing Neuronal Ferroptosis in the Hippocampal Dentate Gyrus. Neurochemical research · 28 Aug 2026 PMID 42663757
  11. UTMD Suppresses CSF-1 to Drive Macrophage-Mediated Ferroptosis in Papillary Thyroid Carcinoma. Cancer medicine · 27 Aug 2026 PMID 42656085
  12. Targeting FAR1 to inhibit intestinal macrophage ferroptosis: repurposing irinotecan as a novel sepsis therapy. Apoptosis : an international journal on programmed cell death · 19 Aug 2026 PMID 42616198
  13. Ferroptosis suppression by MYC confers oxaliplatin resistance in colorectal cancer via FTH1 and GPX4. Cancer chemotherapy and pharmacology · 6 Aug 2026 PMID 42560559
  14. Prognostic risk modeling based on integrated multi-omics analysis identifies CRY2 as a key regulator in tumor immunity and patient survival in colorectal cancer. Annals of medicine · 4 Aug 2026 PMID 42550740
  15. Ferroptosis induction by curcumin through regulating the expression of glutathione peroxidase 4 in papillary thyroid carcinoma. Journal of molecular histology · 4 Aug 2026 PMID 42550316
  16. Metal-dependent cell death in doxorubicin-induced cardiotoxicity and mitigation by luteolin: Network pharmacology and experimental verification. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 30 Jul 2026 PMID 42531631
  17. Ferroptosis modulation enhances astrocyte-to-neuron conversion induced by a novel chemical cocktail in the hemorrhagic brain. Signal transduction and targeted therapy · 29 Jul 2026 PMID 42527413
  18. m6A-methylated circFANCB Promotes Gastric Cancer Progression by Regulating Cellular Ferroptosis Through miR-454-3p/CEACAM5. Journal of biochemical and molecular toxicology · 25 Jul 2026 PMID 42502170
  19. Atranorin suppresses the LUCAT1/STAT3 axis to induce ferroptotic cell death in ovarian cancer. Molecular biology reports · 24 Jul 2026 PMID 42496762
  20. Multifunctional Polydopamine Nanoparticles to Alleviate Oxidative Stress and Inhibit Ferroptosis for Cisplatin-Induced Acute Kidney Injury Therapy. Molecular pharmaceutics · 11 Jul 2026 PMID 42435348
  21. Integrative multi-omics identifies CYP1B1 as a candidate molecular link between toxicant exposure and ferroptosis-related epithelial stress in COPD. Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 11 Jul 2026 PMID 42435052
  22. Calycosin triggers ferroptosis through modulation of the OTUD6B/GPX4 axis to suppress triple-negative breast cancer. Biochemical and biophysical research communications · 9 Jul 2026 PMID 42424934
  23. Dihydropyrano[2,3-b]indoles: Novel dual modulators for lung cancer treatment via autophagy inhibition and ferroptosis induction. Bioorganic chemistry · 7 Jul 2026 PMID 42413401
  24. SMURF1-mediated EFEMP1 ubiquitination reverses the resistance of HCC cells to sorafenib by promoting ferroptosis. Biochemical and biophysical research communications · 6 Jul 2026 PMID 42407434
  25. A Domino-Synthesized Dicoordinate Copper(I) Bis-imidazopyridine Complex Triggering Cuproptosis/Ferroptosis for Enhanced Cancer Immunotherapy. Angewandte Chemie (International ed. in English) · 3 Jul 2026 PMID 42397940
  26. Development of potent BChE/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosis. European journal of medicinal chemistry · 2 Jul 2026 PMID 42391929
  27. Repurposing nitazoxanide as a novel ferroptosis inducer for triple-negative breast cancer via dual disruption of iron homeostasis and the β-catenin/GPX4 axis. Redox report : communications in free radical research · 29 Jun 2026 PMID 42371677
  28. MCL inhibits macrophage ferroptosis through the NRF2/HO-1/GPX4 axis to attenuate carotid atherosclerotic plaque formation. International immunopharmacology · 22 Jun 2026 PMID 42330582
  29. A Keap1-Nrf2 protein-protein interaction inhibitor 4-95 ameliorates cognitive dysfunction by suppressing neuronal ferroptosis. Bioorganic chemistry · 20 Jun 2026 PMID 42322910
  30. Arsenic trioxide triggers ferroptosis in neuroblastoma via USF1/GPX4 axis. Bioorganic chemistry · 20 Jun 2026 PMID 42322906
  31. Bifunctional inhibitors of β-lactamases and ferroptosis: Design, synthesis and anti-gram-negative bacterial infection evaluation. European journal of medicinal chemistry · 16 Jun 2026 PMID 42302665
  32. Reprogramming of TLR-Ferroptosis Signaling and Immunometabolic Pathways Overcomes Myeloid Suppression to Improve Checkpoint Blockade in Prostate Cancer. Cancer research · 15 Jun 2026 PMID 42290280
  33. Pyrazolone functionalized heterocycles promote breast carcinoma cells ferroptosis via suppressing the Nrf-2/ HMOX-1/GPX-4 signaling axis: combined In Silico and In Vitro investigations. Bioorganic chemistry · 12 Jun 2026 PMID 42284881
  34. DIA-based proteomic analysis reveals Scutellaria barbata D. Don Exosome-like nanovesicles promote ferroptosis in HCC through Nrf2/SLC7A11/GPX4 pathway. Functional & integrative genomics · 28 May 2026 PMID 42209785
  35. 5-O-Methylembelin disrupts the ACO1-TPI1 interaction to promote ferroptosis in clear cell renal cell carcinoma. Phytomedicine : international journal of phytotherapy and phytopharmacology · 21 May 2026 PMID 42166976
  36. Reactive Oxygen Species-Responsive Targeted Polydopamine-Rosmarinic Acid Nanotherapeutics for Ferroptosis-Driven Parkinson's Disease Modulation in Caenorhabditis elegans. ACS applied bio materials · 20 May 2026 PMID 42159234
Unclassified: not yet indexed with MeSH (7)
  1. Lithium-Doped Hydroxyapatite Nanowires Rejuvenate Senescent Macrophages Via the Lysosome-Dependent Ferroptosis Axis to Promote Aged Bone Regeneration. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 26 Oct 2026 PMID 42928457
  2. Multi-omics and spatial transcriptomics reveal that S100A10 drives CD8+ T-cell exhaustion and immune evasion in hepatocellular carcinoma through cPLA2-5-LOX-mediated arachidonic acid metabolism and ferroptosis. International immunopharmacology · 13 Sept 2026 PMID 42732672
  3. HPV18-E7 stabilizes HSPA5 to preserve GPX4-dependent redox defense in cervical cancer. Cellular signalling · 22 Aug 2026 PMID 42632529
  4. Mitochondrial ribosomal protein S30 inhibits ferroptosis and promotes tumor progression in hepatocellular carcinoma via suppressing GPX4 ubiquitination. International journal of biological macromolecules · 1 Aug 2026 PMID 42542152
  5. A Ferrous-Supply-Regenerating Lipid Nanoparticle Integrating RNAi Induces Ferroptosis for Cancer Therapy. Small (Weinheim an der Bergstrasse, Germany) · 30 Jul 2026 PMID 42528415
  6. Multi-omics profiling unveils biological and clinical insights into pulmonary sarcomatoid carcinoma. Cell reports. Medicine · 26 Jun 2026 PMID 42361801
  7. Single-Cell Reveal GALNT7-Dependent Ferroptosis Suppression as a Mechanism of Immunotherapy Resistance in Non-Small Cell Lung Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 19 Jun 2026 PMID 42318657